Markets:

Overview

News

Currencies

International

Treasuries

Innoviva, Inc. - Common Stock (NQ:INVA)

22.70 -0.30 (-1.30%)

Streaming Delayed Price Updated: 12:09 PM EDT, Jun 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Innoviva, Inc. - Common Stock

< Previous 1 2 3 4 Next >

A Look Into Healthcare Sector Value Stocks ↗

October 02, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

July 31, 2023

Via Benzinga

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now ↗

July 11, 2023

With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.

Via InvestorPlace

AstraZeneca-Spin Off Entasis Secures FDA Approval For First Pathogen-Targeted Therapy Addressing Acinetobacter ↗

May 24, 2023

Via Benzinga

Over $125M Bet On Occidental Petroleum? Check Out These 4 Stocks Insiders Are Buying ↗

May 16, 2023

Although US stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

May 15, 2023

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

May 08, 2023

Via Benzinga

FDA's AdComm Panel Favors Innoviva's Drug For Multidrug-Resistant Bacterial Infections ↗

April 18, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Innoviva ↗

March 03, 2023

Via Benzinga

Elon Musk Says US Intel Agencies Had Access To Twitter DMs, Alibaba's Ant IPO Might Actually See Light, Airbus Pushes Some 2024 Deliveries: Today's Top Stories ↗

April 18, 2023

Benzinga Elon Musk Drops Bombshell: US Intel Agencies Were Reading Your Twitter DMs

Via Benzinga

Innoviva Earnings Perspective: Return On Capital Employed ↗

December 19, 2022

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

October 03, 2022

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...

Via Benzinga

Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings ↗

September 19, 2022

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

September 19, 2022

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...

Via Benzinga

Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share ↗

May 23, 2022

Via Benzinga

3 No-Brainer Stocks Under $10 to Buy for September ↗

September 02, 2022

Cash-rich investors have the flexibility to buy no-brainer penny stocks to boost overall returns in a risk-adverse environment.

Via InvestorPlace

Innoviva's Return On Capital Employed Overview ↗

August 01, 2022

Pulled from Benzinga Pro data, Innoviva (NASDAQ:INVA) showed a loss in earnings since Q1, totaling $21.37 million. Sales, on the other hand, increased by 20.17% to $108.22 million during Q2.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 28, 2022

On Thursday, 108 companies set new 52-week lows.

Via Benzinga

Innoviva: Q2 Earnings Insights ↗

July 27, 2022

Innoviva (NASDAQ:INVA) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Innoviva missed estimated earnings...

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

July 25, 2022

What is a Value Stock?

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022 ↗

July 20, 2022

Upgrades

Via Benzinga

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures ↗

July 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 13, 2022

Gainers

Via Benzinga

Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests ↗

July 13, 2022

Via Benzinga

La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News ↗

July 11, 2022

A headline-grabbing takeover deal could be impactful for the medical community - and today, it's definitely huge news for LJPC stock holders.

Via InvestorPlace

The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death ↗

July 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal ↗

July 11, 2022

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

June 27, 2022

What Defines a Value Stock?

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

March 28, 2022

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Sail Through the Choppy Market With These 4 Low-Beta Stocks ↗

March 05, 2022

Creating a portfolio of low-beta stocks is important since the securities can deliver healthy returns and provide a shield against volatile market conditions.

Via Talk Markets

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.